These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4019112)

  • 1. Prostaglandins E3 and D3 lower intraocular pressure.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1985 Aug; 26(8):1178-82. PubMed ID: 4019112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
    Goh Y; Nakajima M; Azuma I; Hayaishi O
    Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes.
    Stern FA; Bito LZ
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):588-98. PubMed ID: 7076404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin D2 reduces intraocular pressure.
    Goh Y; Nakajima M; Azuma I; Hayaishi O
    Br J Ophthalmol; 1988 Jun; 72(6):461-4. PubMed ID: 3164634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.
    Bito LZ; Draga A; Blanco J; Camras CB
    Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):312-9. PubMed ID: 6572617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of central regulation of intraocular pressure using ventriculocisternal perfusion.
    Liu JH; Neufeld AH
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):136-43. PubMed ID: 4038694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits.
    Camras CB; Bito LZ; Eakins KE
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1125-34. PubMed ID: 924742
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of interleukin-1alpha on intraocular pressure in rabbit eyes and its focal side effects].
    Wang NL; Chen JC; Fan ZG; Wu HP; Lin H; Qiao LY
    Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):647-51. PubMed ID: 16080902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds.
    Bito LZ
    Exp Eye Res; 1984 Feb; 38(2):181-94. PubMed ID: 6370708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosanoids as a new class of ocular hypotensive agents. 1. The apparent therapeutic advantages of derived prostaglandins of the A and B type as compared with primary prostaglandins of the E, F and D type.
    Bito LZ; Baroody RA; Miranda OC
    Exp Eye Res; 1987 Jun; 44(6):825-37. PubMed ID: 3653276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular effects of substance P in the rabbit.
    Stjernschantz J; Sears M; Stjernschantz L
    Invest Ophthalmol Vis Sci; 1981 Jan; 20(1):53-60. PubMed ID: 6161102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
    Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
    J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosapentaenoic acid metabolism in human and rabbit anterior uvea.
    Kulkarni PS; Srinivasan BD
    Prostaglandins; 1986 Jun; 31(6):1159-64. PubMed ID: 3020617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive observations on eyes of cats after long-term maintenance of reduced intraocular pressure by topical application of prostaglandin E2.
    Bito LZ; Srinivasan BD; Baroody RA; Schubert H
    Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):376-80. PubMed ID: 6572618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Miller PE; Nelson MJ; Rhaesa SL
    Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of prostacyclin and its stable analog on intraocular pressure.
    Hoyng PF; Groeneboer MC
    Prog Clin Biol Res; 1989; 312():369-78. PubMed ID: 2508128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenic responses of the eye to injury. Effect of sensory denervation on the response of the rabbit eye to bradykinin and prostaglandin E1.
    Butler JM; Hammond B
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(4):668-74. PubMed ID: 281800
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
    Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
    Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.